Skip to main content
Caplight Logo









Arontier

Arontier

Private
SeoulHealthcare & Life Scienceshttps://www.arontier.co/

Last Round

Strategic

Jul 2, 2024

Est. Valuation

$28.92M

Total Funding Raised

$3.62M

Company Overview

Arontier is a biotechnology company that develops an AI-driven drug discovery platform for the creation of antibodies, protein binders, and small-molecule drugs to treat incurable and rare diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

drug discoveryAI drug discoveryin silico drug discoveryantibody designprecision medicinesmall molecule designprotein designcomputational biologybioinformaticsneoantigen vaccinebiotech R&Dmultiomicsbiomarker discoveryAI biotechpharma tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arontier Comparables

Compare Arontier with similar companies based on industry and business-model similarity.

Arontier comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DR.NOAH Biotech
85%
Standigm
83%
HITS Inc.
82%

Arontier Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicJul 2, 2024
Series BDec 1, 2021
Series ANov 1, 2020

Arontier Investors

Notable investors and investment history

Arontier investors
InvestorRounds
Harang Technology InvestmentSeries B
HLB InvestmentStrategic
Mirae Asset Venture InvestmentSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors increased 36% MoM.

  • Mar 5, 2026

    Monthly visitors increased 74% MoM.

Arontier Filings

Explore SEC and related filing metadata, where available.

Arontier filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Arontier's valuation, stock price, and market status.

Is Arontier a public or private company?

Arontier is a private company.

What is the current stock price of Arontier?

Arontier is a private company with no public stock price. Caplight tracks Arontier's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Arontier worth (valuation)?

Arontier's valuation is estimated at $28.9M based on funding round data.

Can I buy Arontier stock?

Arontier shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Arontier's last funding round?

Arontier's most recent funding round was Strategic on July 2, 2024.

Who are the main investors in Arontier?

Key investors in Arontier include Harang Technology Investment, HLB Investment, Mirae Asset Venture Investment.

Will Arontier IPO soon?

No public IPO plans have been announced for Arontier.

How can I track Arontier secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Arontier's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range14
Year Founded2017
Last FundingJul 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?